Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TomoTherapy, Avalon come to board solution

This article was originally published in Clinica

Executive Summary

Radiation therapy specialist TomoTherapy has agreed to elect two independent members to its board of directors after being pressed by disgruntled shareholder Avalon Portfolio. Jonathan McCloskey, portfolio manager at Avalon, has joined the TomoTherapy board in a bid to help enhance shareholder value. Madison, Wisconsin-based TomoTherapy has also agreed to employ an additional independent director, thus swelling the number of board members to eleven. Avalon had originally been pushing to have four new board members elected to TomoTherapy’s board (see Clinica No 1331, p 21) after claiming the firm was “squandering its market leadership”.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel